Latest News

Rising UK in-store inflation at 1.5% YoY, higher energy costs linked to the Iran war, and an AI boom pushing up memory and storage prices are colliding to reshape cost pressures and potential earnings power. That mix can hurt some businesses and help others. This article picks out three stocks from our Semiconductor & AI Hardware Suppliers screener that appear well placed in this cross current and explains what the recent news might mean for each one. The three stocks below are just a sample,...

Energy markets are being reshaped by extended sanctions on Russia, shifting diplomacy and Europe’s push to cut reliance on Russian supply. That mix keeps volatility high, which can punish some stocks yet create chances for others as gas trading and storage margins move around. This article explains how that story links to three European Energy Trading and Storage Companies screener stocks that are currently positioned as potential beneficiaries of the latest headlines. The three stocks...

Meridian Energy (NZSE:MEL) has drawn fresh attention after reporting a return to net profit for the year to June 30, 2026, alongside announcing an ordinary and supplementary dividend to shareholders. The earnings rebound and dividend news come after a softer run for Meridian Energy’s share price. It is trading at NZ$5.44 after declining 6.04% over the last 90 days and 4.56% over 30 days, even though the 5-year total shareholder return is 29.02%. Compare Meridian Energy's renewed profit and...

Centene stock has surged over the past year, yet the latest valuation checks still lean on the cheap side for this managed care company. For investors, the question is whether that mix of strong recent returns and an undervalued label can coexist for long. Centene has delivered a 121.6% gain over the past year, which puts extra focus on whether the recent share price already reflects the main improvements in the business. Analysts pointing to margin recovery and steadier earnings quality may...

Bloom Energy (BE) has drawn fresh attention after introducing Power Connect, a deployment system that the company says can cut onsite power installation time by more than 40% and simplify grid bypass for customers. Against this backdrop, Bloom Energy’s share price has been volatile, with the stock down about 32% over the past 90 days but showing a 109% year to date share price return and a very large 3 year total shareholder return. This suggests that momentum has been strong over a longer...

Recent share performance and what it might signal for W. P. Carey W. P. Carey (WPC) has seen its share price decline about 5% over the past month and roughly 5% over the past 3 months, with the stock last closing at US$69.96. For investors, those moves sit against a backdrop of reported annual revenue of about US$1.82b and net income of roughly US$651.01m, alongside a market value near US$16.06b as of the latest data. Recent returns tell a different story over longer periods. The stock shows...

The Morning Bull - US Market Morning Update Tuesday, Sep, 1 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts down about 0.1%, as investors weigh higher government bond yields against a busy week for US economic scorecards. The US 10-year Treasury yield is around 4.7%, after recent comments from former Fed official Kevin Warsh pushed markets to price a greater chance of an interest rate hike in September. As a result, borrowing costs for mortgages, credit...

Freedom Holding (FRHC) has drawn investor attention after recent share price gains, with the stock closing at US$175.01 on 29 August 2026, contributing to strong year to date and multi year total returns. Over the past week and month, Freedom Holding’s share price return of 11.18% and 15.69% respectively suggests momentum has been building, even though the 1 year total shareholder return of 2.39% contrasts with much stronger multi year total returns of 74.02% over three years and 175.82% over...

Tri Chemical Laboratories went into this earnings print with a stock that had slid about 25% over the past three months, even as its trailing P/E of 16.3x sat well below semiconductor peers. The latest quarter did not deliver a clean win or a clear miss. Revenue reached ¥7,216.3m and basic earnings per share came in at ¥46.70, while the trailing net profit margin of 23.3% stayed a touch softer than last year. The key question now is how that combination of earnings power and valuation lines...

CVR Energy (CVI) has drawn attention after recent trading, with the stock last closing at $41.86. Investors are weighing this price against the company’s fundamentals and recent return profile. The recent 10.07% 7-day and 17.52% 30-day share price returns suggest momentum has picked up for CVR Energy, building on a 66.18% year to date share price return and a five year total shareholder return of about 4x, even as investors reassess the risk and reward trade off at $41.86. Spot similar...

Dow stock is coming off a difficult five year stretch, with a material share price decline over that period, yet current valuation checks suggest the market may be pricing the company below what its cash flows imply. Over five years, the share price declined 35.4%, which leaves long term holders with a sizeable loss and raises the question of whether expectations became too low. Future cash flow from Dow's chemicals and materials portfolio can support value if margins and capital spending...

In August 2026, BKV Corporation filed a US$140.17 million shelf registration for 5,315,390 shares of common stock, following a quarter in which its revenue and earnings per share exceeded analyst expectations. The company’s strong Q2 performance highlighted the commercial traction of its integrated natural gas and carbon capture model, setting an important context for potential future capital raises under the new shelf. With BKV’s Q2 earnings outperforming peers, we’ll now examine how this...

Revolution Medicines (RVMD) is in focus after the FDA approved RASONQUE, an oral RAS(ON) inhibitor for adults with metastatic pancreatic adenocarcinoma following prior systemic therapy or for those unsuitable for multiagent regimens. Revolution Medicines’ share price is around US$205.57 after a slight pullback over the past week. The 30 day share price return of 9.62% and 90 day share price return of 35.86% sit against a year to date share price return of 160.15%, while the 1 year total...

Fabrinet has delivered a very strong 5 year share price gain, yet current valuation checks now suggest the stock is closer to fairly priced on intrinsic value while some multiples still look supportive. Recent share price weakness adds another layer, as investors weigh robust business momentum against a Discounted Cash Flow (DCF) estimate that points to only a small premium to the current market price. Over the past 5 years Fabrinet has returned about 293.3%, which puts recent share price...

Eli Lilly (NYSE: LLY) plans to acquire Merida Biosciences to expand its autoimmune and allergic disease pipeline, including lead candidate MER511. The deal is expected to add early stage precision immunology assets to Lilly's existing portfolio in metabolic and neurology treatments. New Phase 3b TOGETHER trial data report durable 52 week efficacy for a Taltz and Zepbound combination in patients with psoriatic disease and obesity. The dual therapy approach targets both psoriatic disease...

Sewage spills on dry days have turned a usually sleepy corner of the UK market into a live wire for investors. Tougher rules, rising public anger and a £12b industry spend on cleaner water could reshape who carries the cost and who wins new business. This article walks through three UK stocks exposed to this sewage story, explaining how the same headlines can mean very different outcomes. The three stocks below are only a starting sample of UK-listed water and pollution-control providers, and...

Double Standard stock came into this quarter on a solid run, yet the latest numbers force investors to rethink how durable that story really is. The share price has been supported by a P/E of 16.7x and a rich 5.12% dividend yield. The headline from this earnings release is margin pressure. Trailing net profit margin is 14.1%, compared with 21.4% a year earlier, while free cash flow coverage of that dividend looks thin. For a stock trading above an estimated cash flow value, that squeeze is...

Dollar General (DG) is back on watch after second quarter 2026 sales of US$11.29b and net income of US$550.32m topped expectations, with management lifting full year guidance and flagging a restart of share buybacks. At a share price of US$126.75, Dollar General has seen a 3.14% 1 day share price return and a 19.27% 90 day share price return. The 1 year total shareholder return of 18.91% contrasts with weaker five year compounding, suggesting that momentum is rebuilding after recent guidance,...

Saab has delivered a very large 5 year return, yet its current valuation screens as expensive on broad checks, which may give some investors pause as they look at the stock today. Over the past 5 years, Saab has returned about 9.3x, which is an unusually strong outcome for existing shareholders and raises the bar for what needs to go right next. Interest in Saab's role in offshore remotely operated vehicles for energy and defense can support high expectations, while any change in defense or...

BlackRock stock has delivered a strong 3 year return, yet current valuation checks flag the shares as not obviously cheap, with an intrinsic value estimate close to the market price while traditional multiples lean richer. BlackRock has returned about 75% over the past 3 years, which puts extra focus on whether the current price leaves much room for further value. Growing involvement in crypto products, including Bitcoin and Ethereum ETFs and related offerings, can support fee based revenue...

Towa Food Service stock came into this earnings print with a steady three month run and a P/E of 22.3x that aligned closely with the broader Japan hospitality group, leaving little room for big surprises in sentiment. The headline from Q1 2027 is a solid profits story. Net income from continuing operations of ¥171 million translated into basic earnings per share of ¥21.19, backed by a trailing twelve month net margin of 5.7% that has held its ground. The question for traders is whether that...

In August 2026, the Australian Prudential Regulation Authority imposed new licence conditions on Bendigo and Adelaide Bank after an independent review by Deloitte found widespread and persistent weaknesses in the bank’s non-financial risk management, governance, and compliance frameworks. This heightened regulatory intervention adds a new layer of operational and oversight requirements just as Bendigo and Adelaide Bank is investing heavily in technology, risk systems and balance sheet...

JBT Marel has had a difficult start to the year, with the share price down 22.4% year to date, yet the valuation checks based on market multiples point to the stock screening as undervalued and the overall value score coming through as mixed rather than clearly cheap or clearly expensive. The share price is down 22.4% year to date, which puts JBT Marel in a weaker recent performance bracket and naturally raises questions about what the current valuation is already pricing in. For JBT Marel,...

Netlist (NLST) is drawing attention after receiving a favorable Momentum Style Score and a high analyst ranking, supported by positive earnings estimate revisions that signal rising interest in the stock among investors. Netlist’s recent share price move to US$6.82 follows a sharp build in short term momentum, including a 30 day share price return of 190.21% and a 90 day share price return of 109.85%, while the one year total shareholder return is approximately seven times the initial...